Objective To measure the effect on genital warts of the national human papillomavirus
vaccination programme in Australia, which started in mid-2007. Design Trend analysis of …

[Anogenital warts incidence, medical management and costs in women consulting
gynaecologists in France]. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

In this Review, we describe the recent epidemiology of genital warts and postulate what the
future may hold as a result of the introduction of the quadrivalent human papillomavirus …

Background For several decades, diagnoses of genital warts at genitourinary medicine
(GUM) clinics in England had been increasing. In 2008, a national human papillomavirus …

ABSTRACT INTRODUCTION: Genital warts (GW) is one of the most prevalent venereal
diseases in Northern Europe today. Previous research has shown that while present, GW …

The treatment of genital warts remains frustrating since it is often painful, expensive, and
unsuccessful. Moreover, little is known about the infectivity and natural history of exophytic …

Background Information on the health-related quality of life (HRQoL) of patients with genital
warts (GW) in populations in mainland China is still limited. The aim of the study was to use …

Genital warts are one of the most commonly reported sexually transmitted diseases
worldwide. A variety of treatment options are available but few have been assessed in large …

Background Australia provided free quadrivalent human papillomavirus vaccines to 12–18-
year-old girls and women aged≤ 26 years from mid-2007 until the end of 2009. After this …

The prevalence of genital warts (GW) and self-reported human papillomavirus (HPV) as well
as disease-related psychosocial impact among male and female patients aged 18–60 years …